| abstract |
The invention provides thiazolidinedione, oxadiazolidinedione, and triazolonencompounds of Formula (I) which compounds are thyroid receptor ligands.n n The invention further provides pharmaceutical compositions and kitsncomprising such compounds and methods of treating obesity, overweight condition,nhyperlipidemia, glaucoma, cardiac arrhythmias, skin disorders, thyroid disease,nhypothyroidism, thyroid cancer, diabetes, atherosclerosis, hypertension, coronarynheart disease, congestive heart failure, hypercholesterolemia, depression, andnosteoporosis using such compounds. |